Northern Trust’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-409,532
Closed -$3.45M – 4340
2015
Q4
$3.45M Buy
409,532
+4,154
+1% +$27.8K ﹤0.01% 2704
2015
Q3
$1.69M Buy
405,378
+336,946
+492% +$1.47M ﹤0.01% 3128
2015
Q2
$361K Buy
+68,432
New +$438K ﹤0.01% 3638

Northern Trust's OCAT Position: Q1 2016 in Review

Northern Trust sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 409,532 shares — an estimated $3.45M sold.

Northern Trust first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $3.45M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Northern Trust reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Northern Trust sold 409,532 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $3.45M.
  • Northern Trust first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Northern Trust's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $3.45M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Northern Trust's 13F filing for Q1 2016, filed 13 May 2016.